ReleaseWire Connect

Fact.MR, in its recent research, offers market forecast and analysis on the blood cancer diagnostics market for the period, 2017-2022. According to the research, the global blood cancer diagnostics market is projected to grow at 6.4% CAGR through 2022. The key takeaways from Fact.MR's research report include,

According to a recent report by Fact.MR, the global lung cancer diagnostics market is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Fact.MR has announced the addition of the “ Ovarian Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.

Patient's dignity and comfort are of paramount importance in the field of medical surgery. Nurses are properly trained on patient positioning principles, and hospitals are also compelled to be equipped with leading products that can facilitate effective patient positioning.

The global speech generating devices market is expected to exhibit a staggering expansion at 12.2% CAGR over the forecast period 2017 to 2022, according to a report by Fact.MR. The report anticipates the market to account for revenues worth US$ 168.6 Mn in 2017, and the market is further estimated to reach nearly US$ 300 Mn by 2022-end.

Fact.MR has announced the addition of the “ Breast Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.

As patients of spinal cord fractures continue to struggle with long duration consumed for complete recovery, surgeons and doctors continue to promote the use of bone growth stimulators. The Fact.MR forecast report on global bone growth stimulator market anticipates that global sales of these devices will bring in more than US$ 1.4 Bn by the end of 2017. Spinal fracture patients opting for bone growth stimulators is expected to rise due to increasing advancements in lowering patient discomfort. By the end of 2022, sales of bone growth stimulators in the global market is pegged to bring in US$ 1.91 Bn, exhibiting a steady growth at 5.3% CAGR.

According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR's report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally. Key takeaways from Fact.MR's report are,

Fact.MR, in its latest research, anticipates the global kidney cancer diagnostics market to witness an impressive expansion at a CAGR of 6.4% over the forecast period 2017 to 2022.

Fact.MR has announced the addition of the “ Prostate Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.